What Happens If Mitochondria Are Damaged?

Damaged mitochondria trigger a cascade of problems that starts with energy failure and quickly branches into oxidative stress, inflammation, and cell death. Because mitochondria supply the vast majority of a cell’s usable energy through a process called oxidative phosphorylation, even partial damage can starve energy-hungry tissues like the brain, heart, and kidneys. But the fallout goes well beyond a drained battery: injured mitochondria leak reactive molecules that harm DNA, proteins, and membranes, and they can release internal components that the immune system treats as foreign invaders. The consequences touch nearly every major disease category, from neurodegeneration and heart failure to cancer and the aging process itself.

The Immediate Fallout Inside a Cell

Mitochondria generate ATP, the molecule cells use as fuel for almost everything they do. When mitochondria are damaged, ATP output drops. At the same time, the electron transport chain that drives energy production becomes leaky, releasing reactive oxygen species (ROS) into the cell. ROS are chemically aggressive molecules that damage whatever they encounter, including the mitochondria’s own DNA, membranes, and proteins. This creates a vicious loop: damaged mitochondria produce more ROS, which cause more damage, which produces still more ROS.¹

Environmental chemicals can kick off this same destructive loop from the outside. Toxins that interfere with the electron transport chain cause excess ROS production, mitochondrial DNA mutations, altered membrane permeability, and disruptions in calcium balance. In many cases, the damage feeds on itself, as a disrupted transport chain generates even more ROS and even less ATP.

If the damage is severe enough, a structure called the mitochondrial permeability transition pore (mPTP) opens wide. Calcium overload and ROS are the main triggers. Once that pore opens, the mitochondrion essentially collapses, and the cell is pushed toward death through either apoptosis (an orderly, programmed shutdown) or necrosis (a messier rupture that spills cell contents into surrounding tissue and provokes inflammation).^{2 3}

How Cells Try to Clean Up the Mess

Cells are not defenseless against mitochondrial damage. They run a quality-control system that detects faulty mitochondria and removes them before they do too much harm. The best-studied version of this cleanup relies on two proteins, PINK1 and Parkin, that work together in a process called mitophagy, essentially autophagy targeted specifically at mitochondria.

Here is how it works in broad strokes. Healthy mitochondria maintain an electrical charge across their inner membrane (their membrane potential). When a mitochondrion is damaged and loses that charge, PINK1 rapidly accumulates on its outer surface instead of being imported and broken down as it normally would be.⁴ The buildup of PINK1 acts as a distress flag, recruiting Parkin from elsewhere in the cell. Parkin then tags the damaged mitochondrion with molecular labels that mark it for destruction by the cell’s recycling machinery.⁵ Research using genome-wide screens has shown that diverse forms of mitochondrial damage all converge on the same signal, loss of membrane potential, to activate this PINK1-Parkin pathway.⁶

Mitochondria also use a second strategy: they constantly fuse with each other and split apart. Fusion lets a mildly damaged mitochondrion mix its contents with a healthy neighbor, diluting defective components and sharing functional ones. Fission lets the network pinch off a severely damaged segment so it can be isolated and destroyed. When the balance between fusion and fission goes wrong, the consequences are serious. Even mild defects in this dynamic balance have been linked to cancer, neurodegenerative diseases, and cardiovascular disease.^{7 8}

Why Mitochondrial DNA Is Especially Vulnerable

Mitochondria carry their own small genome, separate from the DNA in the cell nucleus. This mitochondrial DNA (mtDNA) encodes some of the key components needed for energy production. Unfortunately, mtDNA sits right next to the electron transport chain where ROS are generated, and unlike nuclear DNA, it is not wrapped in protective histone proteins. The result is that mtDNA picks up mutations far more easily than nuclear DNA, and the rate of these mutations rises sharply with age.⁹

A single cell can contain hundreds or thousands of copies of mtDNA. Not all copies need to be mutated for problems to appear, but there is a threshold. A systematic review of studies on one well-characterized mutation found that when the proportion of mutant copies exceeded roughly 60% in skeletal muscle, the energy-producing enzyme complex it affected showed measurably reduced activity.¹⁰ Below that threshold, healthy copies can compensate. Above it, the cell begins to struggle. The exact tipping point varies by tissue and by which mutation is involved, which partly explains why mitochondrial diseases can look so different from one person to another.

The Brain Takes the Hardest Hit

Neurons are among the most energy-demanding cells in the body, and they cannot easily switch to backup energy sources the way some other cell types can. That makes the brain uniquely vulnerable to mitochondrial damage. The loss of energy production, the rise in oxidative stress, and disrupted calcium handling are all hallmarks of neurodegenerative disease.¹¹ Oxidative stress from malfunctioning mitochondria has been implicated in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis, and Friedreich’s ataxia.¹²

The Parkinson’s connection is especially telling. Researchers genetically disrupted the function of complex I, a critical part of the electron transport chain, specifically in the dopamine-producing neurons of mice. The neurons initially survived by shifting their metabolism away from mitochondrial energy production, but they progressively lost their ability to release dopamine. Over time the mice developed symptoms closely resembling human Parkinson’s disease, including motor deficits that responded to levodopa, the standard Parkinson’s drug. The finding demonstrated that damage to a single mitochondrial complex, in one type of neuron, is by itself enough to cause progressive parkinsonism.¹³ It also reinforced why mutations in the PINK1 and Parkin genes, the same cleanup proteins described earlier, are among the most common genetic causes of early-onset Parkinson’s. When the cleanup system is broken, damaged mitochondria accumulate in neurons that can least afford to carry them.

Heart, Kidneys, and Muscle

The heart beats roughly 100,000 times a day, and nearly all the energy for that comes from mitochondrial oxidative metabolism. When mitochondria in heart cells fail, the consequences go beyond a simple power shortage. Damaged mitochondria release toxic byproducts and trigger inflammatory pathways that actively worsen the cardiac tissue around them, creating a cycle in which compensatory mechanisms eventually become destructive.¹⁴ During a heart attack, the sudden loss and then restoration of blood flow (ischemia-reperfusion) is particularly damaging to mitochondria, impairing energy production and flooding cells with ROS.^{15 16}

Kidney tubule cells, which handle the enormous workload of filtering blood, are similarly packed with mitochondria. When those mitochondria are injured, the tubule cells undergo metabolic disruption, oxidative stress, calcium imbalance, and ultimately cell death, all of which drive kidney disease.¹⁷ Mitochondrial damage in early acute kidney injury has been identified as a key factor in whether the kidneys recover or progress to chronic kidney disease.¹⁸ In sepsis, a condition where infection triggers widespread inflammation, spatial protein mapping of injured kidneys has revealed multiple distinct pathways of mitochondrial damage at work simultaneously, including disrupted energy production, iron-driven membrane damage, and excessive mitophagy that removes too many mitochondria.¹⁹

In skeletal muscle, the link between mitochondrial damage and everyday function is hard to miss. People with inherited mitochondrial myopathies, where genetic mutations reduce the energy-producing capacity of muscle mitochondria, experience exercise intolerance and fatigue at workloads that would be trivial for someone with healthy mitochondria. Modeling studies have shown that a sufficiently large drop in oxidative phosphorylation activity accounts for many of the distinctive features of these conditions: slower oxygen uptake at the start of exercise, reduced peak oxygen consumption, and lactic acid buildup at surprisingly low effort levels.²⁰

Mitochondrial Damage and Cancer

The relationship between mitochondrial damage and cancer is not what you might expect. Rather than simply dying, cells with dysfunctional mitochondria sometimes pivot to a different way of generating energy: they ramp up glucose uptake and ferment it into lactate, even when oxygen is available. This metabolic shift is called the Warburg effect, and it is one of the defining features of cancer metabolism.²¹ Cancer cells massively increase their use of glycolysis and divert the resulting products away from the mitochondrial energy cycle, even though this is a far less efficient way to produce ATP.²²

Why would cancer cells use a less efficient energy source? The answer seems to be that glycolysis, while producing less energy per molecule of glucose, generates a flood of intermediate molecules that cancer cells repurpose as building blocks for rapid growth and proliferation.²³ Mitochondrial damage, in this context, is not just an unfortunate side effect of cancer but may actually facilitate tumor progression by pushing cells toward this growth-friendly metabolic state. The mouse Parkinson’s study mentioned earlier showed the same principle at work in neurons: when complex I was knocked out, neurons performed a Warburg-like metabolic shift to survive, at the cost of gradually losing their specialized function.¹³

When Your Immune System Mistakes Mitochondria for Bacteria

Mitochondria descended from bacteria that were engulfed by an ancient host cell billions of years ago. They still carry remnants of that bacterial ancestry: their own circular DNA, their own ribosomes, and distinctive membrane lipids like cardiolipin. Normally, these components stay safely inside the mitochondrion, where the immune system ignores them. But when mitochondria are damaged and their contents leak into the cell’s interior or into the bloodstream, the immune system recognizes those molecules through the same receptors it uses to detect invading bacteria.²⁴

Leaked mitochondrial DNA is a particularly potent trigger. It activates inflammatory pathways by binding to DNA-sensing receptors that evolved to catch bacterial infections.²⁵ This means mitochondrial damage does not only harm cells directly through energy failure and ROS; it can also provoke chronic, sterile inflammation, the kind of low-grade immune activation that shows up in aging, autoimmune conditions, and organ injury after trauma or surgery. Because mitochondria were once bacteria, the parallels between how the body responds to mitochondrial debris and how it responds to bacterial infection are, in hindsight, not surprising.²⁶

The Aging Connection

Mitochondrial dysfunction has emerged as one of the recognized hallmarks of aging. The pattern is self-reinforcing: as we age, mitochondrial DNA accumulates mutations, the quality-control systems that remove damaged mitochondria become less efficient, and the resulting buildup of poorly functioning mitochondria generates more ROS and more inflammation. This decline is linked to the development of metabolic syndrome, neurodegenerative disorders, cardiovascular diseases, and cancer.²⁷

At the cellular level, mitochondrial damage drives a phenomenon called senescence, where cells stop dividing but refuse to die. Senescent cells accumulate with age and secrete inflammatory molecules that damage neighboring tissue. Mitochondrial dysfunction is both a cause and a consequence of this process: impaired mitochondria push cells into senescence, and senescent cells further deteriorate their own mitochondria, creating a feedback loop that sustains the senescent state.²⁸

Can You Repair or Prevent Mitochondrial Damage?

The most accessible intervention is also the most pedestrian: exercise. Moderate physical activity stimulates the creation of new mitochondria (mitochondrial biogenesis), effectively replenishing the pool of functional mitochondria in your cells. Calorie restriction produces a similar effect, and both pathways appear to work through the same master regulator of mitochondrial production.²⁹ This is one of the better-established reasons why regular exercise is protective against so many age-related diseases: it directly counteracts the mitochondrial decline that underlies many of them.

On the pharmaceutical side, researchers are investigating compounds that boost levels of NAD+, a molecule central to mitochondrial energy production that declines with age. In mouse models of Parkinson’s disease, supplementation with an NAD+ precursor called NMN improved mitochondrial quality control, reduced inflammation, inhibited cell death, and prevented motor deficits and brain damage.³⁰ These results are promising but still animal-stage work; whether NAD+ precursors meaningfully slow mitochondrial decline in humans remains an open and heavily studied question.

For inherited mitochondrial diseases, where the damage is written into the DNA itself, a more radical approach exists: mitochondrial replacement therapy. Sometimes called “three-parent IVF,” the technique takes the nuclear DNA from an egg or embryo carrying defective mitochondria and places it into a donor egg with healthy mitochondria, producing a child with nuclear DNA from both parents and mitochondrial DNA from a donor.³¹ Because there are no effective cures for most inherited mitochondrial diseases, and prenatal screening has significant limitations, prevention of transmission through germline gene replacement has attracted serious clinical attention.³² The United Kingdom approved the technique in 2015, and a small number of clinical cases have been reported internationally.

Measuring Mitochondrial Health From a Blood Draw

One of the challenges with mitochondrial dysfunction is that it is difficult to measure in living people without taking a tissue biopsy. You cannot easily sample someone’s brain, heart, or kidney mitochondria just to check how they are performing. But a newer approach sidesteps this problem by looking at platelets, the small cell fragments in blood that are involved in clotting. Platelets are packed with active mitochondria, and their energy profile appears to mirror what is happening in other tissues. Researchers are exploring platelet bioenergetics as a kind of liquid biopsy for mitochondrial function, one that could be used to diagnose disease, track progression, and monitor whether treatments are working.³³ The field is still young, but the appeal of a simple blood test that reveals systemic mitochondrial health is obvious, especially for conditions like neurodegeneration and heart failure where mitochondrial damage is central but hard to access directly.